Westin T, Stein H, Niedobitek G, Lundholm K, Edstrm S
Currently, no dietary supplement patch has been approved by the FDA for weight loss or to manage obesity
But purity doesn't eliminate the need for due diligence on your end
The compound does not exist as a stable free molecule in the body
Frail older people may be particularly vulnerable to nutritional deficiencies if appetite suppression is excessive, potentially contributing to unintentional weight loss and sarcopenia
FDA approves GLP-1 pill for obesity nature.com/articles/d4157 Eli Lillys orforglipron is the first small-molecule GLP-1 receptor agonist to secure approval, offering a potential convenience edge over established peptidic GLP-1-based obesity drugs FDA approves GLP-1 pill for obesity nature.com/articles/d4157 Eli Lillys orforglipron is the first small-molecule GLP-1 receptor agonist to secure approval, offering a potential convenience edge over established peptidic GLP-1-based obesity drugs